Notably, some mutations—such as those in BAP1 and PBRM1—occur mutually exclusively, suggesting distinct molecular subtypes of ccRCC with prognostic relevance [105]. This evidence concerns the gene BAP1 and nonpapillary renal cell carcinoma.